FORMULATION AND EVALUATION OF GOLDEN SEA CUCUMBER (STICHOPUS HERRMANNI) ORAL SUSPENSION
Main Article Content
Abstract
The Golden Sea Cucumber (Stichopus herrmanni) is widely recognized for its high protein and collagen content, making it valuable for medicinal applications, such as wound healing and tissue regeneration. The present study focused on formulating an oral suspension of sea cucumber extract, assessing its stability, and determining its protein content. Extraction was performed using a boiling method with distilled water to yield a protein-rich extract, which was then formulated into four suspension formulas (Formula 1, 2, 3, and 4) using pharmaceutical-grade excipients, including sorbitol, sodium CMC, and sodium benzoate. Protein quantification was conducted using the Biuret method with Bovine Serum Albumin (BSA) as a standard and analyzed using UV-Vis spectrophotometry. Stability testing over 1, 3, and 6 months was used to evaluate pH, viscosity, and sensory characteristics (odor, color, and taste). Among the four formulations, formula 4 demonstrated the highest stability, maintaining optimal homogeneity, sensory attributes, and pH, along with the highest protein concentration (8.10 mg/mL. These results highlight Formula 4 as the most promising because of its superior stability and protein content. This study underscores the challenges of long-term stability in protein-based suspensions, suggesting the need for further research into advanced excipient selection and encapsulation techniques to protect sensitive proteins. Overall, this research supports the potential use of marine-derived bioactive compounds in pharmaceutical applications, paving the way for sustainable healthcare and cosmetic products.
Keywords: golden sea cucumber, Stichopus herrmanni, oral suspension formulation, stability test
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice
 The author whose manuscript was published agreed to the following provisions:
- The publication right of all journal material published / released on the E-Journal website of the Medical Science Journal: The Pharmaceutical Scientific Journal is held by the editorial board with the author's knowledge (the moral rights remain the manuscript's author).
- Formal legal provisions for access to digital articles in electronic journals are subject to Creative Commons Attribution-ShareAlike (CC BY-SA) license terms, which means Medical Science Journal: Pharmaceutical Scientific Journal has the right to store, transfer media / format, manage in the form of database (database), maintain, and publish articles without asking permission from the author as long as they include the author's name as the copyright owner.
- Manuscripts that are published / released in print and electronically are open access for educational, research and library purposes. In addition to these objectives, the editorial board is not responsible for violations of copyright law.
Â
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.